Convexity Labs

XP

Convexity Analyst · XP
Sellhigh confidenceTactical · no named thesis
Generated Jun 21, 2026

Analyst Note: XP Inc. (XP)

Date: 2026-06-20 Event Date: 2026-06-20

1. Structural Readiness

  • Conservative Entry: 21.48
  • Current Price: 15.30
  • Extension: -28.8% vs. conservative entry

2. Thesis Layer

Thesis Classification: Tactical / Setup-Led Secular Thesis: None

As of 2026-06-20, there is no named secular thesis attached to this setup. The investment case is strictly tactical, driven by the structural setup quality and immediate business fundamentals rather than a broad macro or thematic overlay. The analysis must rely entirely on the quality of the setup (which is currently failed) and the underlying business execution reported by management. No macro thesis should be invented to justify the position; the setup failure is the primary signal.

3. Business Overview

Company: XP Inc. Industry: Financial Services / Wealth Management Business Model: XP operates as a comprehensive financial ecosystem in Brazil, primarily serving retail and institutional clients through a hybrid model of direct distribution and an Independent Financial Advisor (IFA) network.

Key Business Components (as of source dates ≤ 2026-06-20):

  • Revenue Drivers: The company generates income through management fees, performance fees, and transaction fees on investment fund quotas (both third-party and internally managed). As noted in the 2026-04-29 SEC filing, distributing investment fund quotas represents a "relevant part of our business."
  • Client Segments:
  • Retail: XP serves retail clients through a "goal-based investing" value proposition and managed portfolios. In Q1 2026, the company posted $19 billion of organic retail net new money.
  • High Income: Described by management as the "core segment," where XP claims to be a "pioneer in democratizing access to financial and wealth planning in Brazil."
  • Private Banking: The firm continues to gain market share in this segment by leveraging its broader ecosystem.
  • Institutional: The business relies on institutional brokerage clients using XP's solutions and trading platforms.
  • Distribution Network: As of December 31, 2025, XP CCTVM's individual IFAs served approximately 25% of XP CCTVM's active clients, highlighting the importance of the advisor network in client acquisition and retention.
  • Growth Context: In the May 18, 2026 earnings transcript, management stated, "we are confident we can return to double digit growth supported by stronger execution across key verticals and a more diversified revenue base." They noted that while corporate and institutional flows were negative BRL 4 billion in Q1, the total net new money for the quarter was approximately BRL 14 billion.

4. Archetype and Conviction

Archetype: Quality Compounder Fit Analysis: XP fits the Quality Compounder archetype based on its historical ability to scale assets under management (AUM) and its diversified revenue base. Management's confidence in "double digit growth" and the "more diversified revenue base" supports this classification. The business model relies on recurring fee income from a growing client base, a hallmark of compounders.

Conviction Stack:

  • Thesis Strength: Low (No named secular thesis; purely tactical).
  • Evidence Quality: Moderate to High. Management provided specific figures ($19B retail inflows, 25% IFA penetration) and clear strategic direction (goal-based investing, private banking expansion).
  • Setup Readiness: Invalidated. The coil is stopped. The price is 28.8% below the conservative entry and 13.9% below the stop.

ATR Context:

5. Invalidating/Strengthening Factors and Gaps

Invalidating Factors:

  • Flow Reversal: If the "double digit growth" guidance is missed in subsequent quarters, or if retail inflows turn negative again, the "Quality Compounder" thesis weakens.
  • Macro Shift: If the "interest rate easing cycle" stalls or the U.S. Dollar strengthens significantly, the macro tailwinds cited by management could evaporate.

Strengthening Factors:

  • Execution: Successful delivery of the "double digit growth" and "diversified revenue base" as promised in the May 2026 transcript.
  • IFA Expansion: Increasing the share of clients served by IFAs beyond the 25% recorded in late 2025.
  • Private Banking Share: Continued market share gains in the private banking segment.

Evidence Gaps:

  • Valuation Metrics: No specific P/E, P/B, or EV/EBITDA multiples are provided in the evidence block for 2026-06-20.
  • Profitability Margins: While revenue growth is discussed, specific margin expansion data or net income figures for Q1 2026 are not detailed in the provided evidence.
  • Capex/Guidance: No specific capital expenditure plans or detailed forward guidance beyond the "double digit growth" statement are available.

PRIVATE ANALYST CALL

Judgment: Sell Confidence: high Key risks: Continued erosion of retail inflows; failure to execute on double-digit growth guidance; macro headwinds from a stronger USD or stalled rate cuts. Sizing hint: Zero position; capital preservation required due to structural failure. Expected path: Management expects double-digit growth and rate easing benefits, but current price action indicates the market is pricing in a failure to meet these expectations or a deterioration in near-term flows. Failure mode to watch: A sustained close below 15.30 with no recovery toward 18.49, confirming the breakdown of the support structure.

Loading chart...
Exhibit 1: XP daily candlestick — no active setup overlay.

Source-backed evidence anchors and catalysts land once Convexity finishes coverage for XP.

Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.

Value picture unavailable — no financial spine on file for XP.

Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.

Coverage: